We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The results suggest that one death would be prevented for every eight ventilated patients treated and one in every 25 for patients receiving oxygen alone. Read More
The University of Oxford’s RECOVERY trial has found that a cheap and widely available steroid provides a benefit in COVID-19 patients and should become standard of care in patients sick enough to require oxygen. Read More
Eli Lilly has begun enrolling patients for a phase 3 trial of its rheumatoid arthritis treatment Olumiant (baricitinib) for hospitalized COVID-19 patients. Read More
Maryland-based Emergent BioSolutions has signed an $87 million contract with AstraZeneca to support development and production of the UK company’s COVID-19 vaccine, one of the leading candidates in the global race for an effective product. Read More
The kinase inhibitor is approved for treatment of rheumatoid arthritis in adults whose disease is not well-controlled using other medications. Read More
The company is scaling production to have hundreds of thousands of preventative doses or tens of thousands of larger treatment doses per month by the end of August. Read More
Researchers funded by the National Institutes of Health (NIH) are evaluating drugs doctors are using to treat COVID-19 in infants, children and adolescents. Read More